Amylyx Pharmaceuticals News

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 15 22:19 ET

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 15, 2023 16:12 ET

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 16, 2023 16:33 ET

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 15, 2023 16:29 ET

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 17, 2023 16:13 ET

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 16, 2023 17:25 ET

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 16, 2023 16:52 ET

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 16, 2023 16:51 ET

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 16, 2023 16:46 ET

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 16, 2023 16:44 ET

Amylyx Pharmaceuticals | 424B4: Prospectus

Oct 7, 2022 16:30 ET

Amylyx Pharmaceuticals | EFFECT: Others

Oct 7, 2022 00:15 ET

Amylyx Pharmaceuticals | 424B4: Prospectus

Jan 10, 2022 16:02 ET

Amylyx Pharmaceuticals | EFFECT: Others

Jan 7, 2022 00:15 ET

Amylyx Pharmaceuticals | 8-A12B: Registration of a class of securities on a national securities exchange

Jan 4, 2022 16:02 ET

Amylyx Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jan 4, 2022 08:34 ET